Impact of SARS-CoV-2 infection and vaccination on cesarean section outcomes: a retrospective analysis
Open Access
- 1 September 2024
- journal article
- research article
- Published by King Faisal Specialist Hospital and Research Centre in Annals of Saudi Medicine
- Vol. 44 (5) , 306-318
Abstract
BACKGROUND: Pregnant individuals have faced unique challenges during the COVID-19 pandemic, necessitating a closer examination of maternal and fetal health outcomes. OBJECTIVES: Investigate the morbidity and mortality associated with SARS-CoV-2 infection among pregnant individuals, considering vaccination status and variant strains. DESIGN: Retrospective cohort SETTING: Tertiary state hospital PATIENTS AND METHODS: Patients who underwent cesarean sections were categorized into three periods: pre-vaccination (before 31 August 2021), early post-vaccination (from September 2021), and late post-vaccination (aligned with 70% immunization coverage by 2 September 2021). Data collected included demographic information (age, gravidity, parity count, gestational age, newborn APGAR scores), cesarean section indications, chronic diseases, vaccination status, vaccine type and doses, SARS-CoV-2 variant status, ICU admission, and mortality due to COVID-19. MAIN OUTCOME MEASURES: ICU admission and mortality rates, focusing on the impact of SARS-CoV-2 infection and vaccination status. SAMPLE SIZE: 297 COVID PCR-positive symptomatic patients who underwent cesarean sections. RESULTS: In the pre-vaccination group, there were 13 mortalities (8.1%) compared to 9 (6.6%) post-vaccination ( P =.610). Maternal ARDS was seen in 46.2% of pre-vaccination mortalities versus 11.1% post-vaccination ( P =.045). COVID-19 delta variant patients had higher ICU admission (80%) and mortality rates (40%). Rates of COVID-19 PCR-positive cesarean sections, ICU admissions, and mortality declined significantly in early ( P =.021, P =.004, P =.009), respectively and late post-vaccination periods ( P <.001, P <.001, P =.0019), respectively. Vaccinated patients had no ICU admissions or mortality. CONCLUSIONS: Vaccination against COVID-19 is crucial for pregnant individuals as it significantly reduces the risk of severe illness. While vaccines offer substantial protection, the pandemic’s acute phase might be waning, yet COVID-19 remains a global threat, particularly in regions with limited vaccine access. Continued vigilance and proactive measures are essential to mitigate ongoing risks and the emergence of new variant strains. LIMITATIONS: Retrospective observational design and the single-center setting, which may affect the generalizability of the findings.Keywords
This publication has 29 references indexed in Scilit:
- Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysisInternational Journal of Infectious Diseases, 2021
- Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care SettingsNew England Journal of Medicine, 2021
- Recent advances in SARS-CoV-2 Spike protein and RBD mutations comparison between new variants Alpha (B.1.1.7, United Kingdom), Beta (B.1.351, South Africa), Gamma (P.1, Brazil) and Delta (B.1.617.2, India)Journal of Virus Eradication, 2021
- Effectiveness of an Inactivated SARS-CoV-2 VaccineNew England Journal of Medicine, 2021
- Rapid screening for SARS-CoV-2 variants of concern in clinical and environmental samples using nested RT-PCR assays targeting key mutations of the spike proteinWater Research, 2021
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination SettingNew England Journal of Medicine, 2021
- Pandemics Throughout HistoryFrontiers in Microbiology, 2021
- Transmission Dynamics of an Outbreak of the COVID-19 Delta Variant B.1.617.2 — Guangdong Province, China, May–June 2021China CDC Weekly, 2021
- Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental FactorsAnnals of Internal Medicine, 2021
- Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literatureVaccine, 2017